Madras Medical College and Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu, India.
Madras Medical College, Chennai, Tamil Nadu, India.
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211035094. doi: 10.1177/21501327211035094.
Coronavirus disease 2019 (COVID-19) pandemic is a worldwide public health crisis. During huge surge in COVID-19 cases, most of the patient arrived at Rajiv Gandhi Government General Hospital, Chennai were severe due to late presentation and also available evidence demonstrating that the delay in treatment is directly associated with increased mortality or poor patient outcome. As an innovative concept of Zero Delay COVID-19 Ward were set up to provide the required critical care for all severe COVID-19 cases. The experience of setting up of such Zero Delay COVID-19 Ward and profile of admitted COVID-19 patients were described in this paper.
A total of 4515 laboratory-confirmed COVID-19 patients admitted at Zero Delay COVID-19 Ward was analyzed retrospectively from 7th July to 31st December 2020.
At the time of admission the frequency of dyspnea were 85.6% among them 99.1% recovered from dyspnea after the oxygen therapy and other management at Zero Delay COVID-19 Ward. Of the 4515 COVID-19 individuals, about 1829 (40.5%) had comorbidity, 227 (5%) had died. Multivariable logistic regression analysis, COVID-19 death was more likely to be associated with comorbidity (OR: 18.687; 95% CI: 11.229-31.1) than other variables.
Comorbidity is an independent high risk factor for mortality of COVID-19 patients. From our observation, it is strongly recommended that effective zero delay covid-19 ward model will help for the prevention of mortality in current/expected waves of COVID-19.
2019 年冠状病毒病（COVID-19）大流行是一场全球性的公共卫生危机。在 COVID-19 病例剧增期间，由于就诊延迟，大多数到达钦奈拉吉夫·甘地政府总医院的患者病情严重，而且现有证据表明，治疗的延迟与死亡率增加或患者预后不良直接相关。为了给所有重症 COVID-19 病例提供所需的重症监护，我们创新性地设立了零延迟 COVID-19 病房。本文介绍了设立这种零延迟 COVID-19 病房的经验以及入住 COVID-19 患者的特征。
回顾性分析了 2020 年 7 月 7 日至 12 月 31 日期间在零延迟 COVID-19 病房住院的 4515 例实验室确诊的 COVID-19 患者。
在入院时，呼吸困难的频率为 85.6%，其中 99.1%的患者在零延迟 COVID-19 病房接受氧疗和其他治疗后呼吸困难得到缓解。在 4515 例 COVID-19 患者中，约 1829 例（40.5%）有合并症，227 例（5%）死亡。多变量逻辑回归分析显示，与其他变量相比，合并症与 COVID-19 死亡更相关（OR：18.687；95%CI：11.229-31.1）。
合并症是 COVID-19 患者死亡的独立高危因素。根据我们的观察，强烈建议采用有效的零延迟 COVID-19 病房模式有助于预防当前/预期的 COVID-19 浪潮中的死亡率。
